Press Releases
2008
November
11/10/2008Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
11/07/2008
Cepheid to Webcast Upcoming Financial Presentations
11/04/2008
Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA
11/03/2008
Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
October
10/28/2008Cepheid Reports Third Quarter Revenue of $44.9 Million
10/27/2008
Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
10/15/2008
Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA
10/07/2008
Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
10/03/2008
Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
10/01/2008
Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
September
09/29/2008Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
09/26/2008
California Legislation Highlights Need for Broad Menu of Tests in Growing Healthcare Acquired Infection Market
August
08/22/2008Cepheid to Webcast Upcoming Financial Presentations
July
07/29/2008Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
07/28/2008
Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of 'Start Clean' Strategy
07/24/2008
Cepheid Reports Second Quarter Revenue of $42.1 Million
07/21/2008
Cepheid to Webcast Analyst Event
07/14/2008
Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
07/09/2008
Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
June
06/04/2008Cepheid Management to Present at the 7th Annual Needham Medical Technology and Biotechnology Conference and William Blair's 28th Annual Growth Stock Conference
06/03/2008
Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
May
05/20/2008Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization
05/12/2008
Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations
05/06/2008
Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
05/01/2008
Cepheid Reports Record Revenue of $44.8 Million
April
04/07/2008Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
04/03/2008
Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing
March
03/12/2008Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
03/10/2008
Cepheid to Present at Cowen and Company's 28th Annual Healthcare Conference
February
02/28/2008Cepheid Reports Fourth Quarter and Full Year 2007 Results
02/25/2008
Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
02/11/2008
Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
02/06/2008
Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
January
01/29/2008Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
01/07/2008
Cepheid Begins Shipment of Next Generation GeneXpert(R) Molecular Diagnostic Systems
01/03/2008
Cepheid to Present at the Needham Tenth Annual Growth Stock Conference
2007
December
12/06/2007Cepheid to Present at the RBC Capital Markets 2007 Healthcare Conference
12/04/2007
Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
November
11/29/2007Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
11/20/2007
Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
11/01/2007
Cepheid Reports Third Quarter 2007 Results
October
10/23/2007Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results